Azzad Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,951
Closed -$1.42M 339
2025
Q2
$1.42M Sell
10,951
-25
-0.2% -$3.63K 0.15% 199
2025
Q1
$1.75M Buy
+10,976
New +$1.99M 0.21% 171
2024
Q4
Sell
-10,971
Closed -$2.32M 231
2024
Q3
$2.32M Buy
10,971
+15
+0.1% +$2.61K 0.26% 154
2024
Q2
$1.47M Buy
10,956
+4,160
+61% +$787K 0.17% 191
2024
Q1
$1.46M Buy
6,796
+1
+0% +$196 0.17% 194
2023
Q4
$1.38M Buy
6,795
+1,606
+31% +$260K 0.18% 197
2023
Q3
$1.03M Buy
5,189
+3,241
+166% +$817K 0.15% 208
2023
Q2
$632K Buy
+1,948
New +$557K 0.08% 262

Other funds holding INSP

Azzad Asset Management's INSP Position: Q3 2025 in Review

Azzad Asset Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 10,951 shares — an estimated $1.42M sold.

Azzad Asset Management first reported a position in INSP in Q2 2023 and held it in 8 quarters. The position peaked at $2.32M in Q3 2024. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Azzad Asset Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Azzad Asset Management sold 10,951 Inspire Medical Systems shares in Q3 2025, an estimated $1.42M.
  • Azzad Asset Management first reported a position in Inspire Medical Systems in Q2 2023 and held it in 8 quarters.
  • Azzad Asset Management's Inspire Medical Systems position peaked at $2.32M in Q3 2024.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Azzad Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.